Phreesia PHR 深 滬
交易中 12-23 10:58:09 美东时间
16.71
+0.240
+1.46%
華盛通- 最 高16.71
- 今 開16.455
- 成交量 24.04万股
- 最 低 16.40
- 昨 收 16.47
- 總市值 10.01亿
- 52周最高 32.76
- 市盈率 靜 --
- 換手率 0.40%
- 52周最低 15.41
- 委 比 -8.47%
- 總股本 5991.45万
- 歷史最高 81.592
- 量 比 0.99
- 振 幅 1.88%
- 歷史最低 12.05
- 每 手 1
- 風險率 3.12%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅263.64%！Milestone Pharmaceuticals获富国银行升目标价至8美元，维持"超配"评级
今日重点评级关注：富国银行：维持Milestone Pharmaceuticals"超配"评级，目标价从4美元升至8美元；富国银行：维持Kyverna Therapeutics"超配"评级，目标价从31美元升至33美元
12-17 10:46
美股大行评级 | 超配！大摩上调回声星通信评级；汽车地带、CBRL、金宝汤、家得宝等遭多家大行下调目标价
今日重点评级关注：Ascendiant Capital：维持Lucid Diagnostics"买入"评级，目标价从8美元升至8.25美元；Ascendiant Capital：维持Aytu BioPharma"买入"评级，目标价从12.5美元升至13美元
12-11 10:33
美股大行评级 | 花旗上调苹果目标价升至330美元；GPCR、KYMR、MAMA、TERN、WVE等获多家机构上调目标价
今日重点评级关注：Chardan Capital：维持Senti Biosciences"买入"评级，目标价从12美元升至13美元；Guggenheim：维持Praxis Precision Medicine"买入"评级，目标价从540美元升至760美元
12-10 10:33
Barclays Initiates Coverage On Phreesia with Overweight Rating, Announces Price Target of $26
Barclays analyst Glen Santangelo initiates coverage on Phreesia (NYSE:PHR) with a Overweight rating and announces Price Target of $26.
12-10 00:11
美股大行评级 | 潜在涨幅2566.67%！Ascendiant Capital上调GRI Bio目标价至36美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持GRI Bio"买入"评级，目标价从35美元升至36美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从7.75美元升至8美元
12-09 10:32
Phreesia adjusts fiscal 2026 revenue outlook; introduces FY27 guidance
Backed by strong fiscal 2026 Q3 financial results, Phreesia is narrowing its revenue guidance range for the year. The software-as-a-service and payment platform provider for the healthcare industry no...
12-09 07:13
Phreesia Narrows FY2026 Sales Guidance from $472.000M-$482.000M to $479.000M-$481.000M vs $478.148M Est
Phreesia (NYSE:PHR) narrows FY2026 sales outlook from $472.000 million-$482.000 million to $479.000 million-$481.000 million vs $478.148 million estimate.
12-09 05:05
Phreesia Q3 EPS $0.07 Misses $0.24 Estimate, Sales $120.333M Beat $120.052M Estimate
Phreesia (NYSE:PHR) reported quarterly earnings of $0.07 per share which missed the analyst consensus estimate of $0.24 by 70.83 percent. This is a 128 percent increase over losses of $(0.25) per share from the same
12-09 05:04
Earnings Scheduled For December 8, 2025
Companies Reporting Before The Bell • 51 Talk Online Education (AMEX:COE) is li...
12-08 19:11
Dow Surges Over 100 Points Ahead Of Interest-Rate Decision: Greed Index Remains In 'Fear' Zone
The Fear & Greed Index is a measure of market sentiment, showing a slight increase in fear levels on Friday with the Dow Jones up and Fed rate cut expectations.
12-08 14:11
